Cancer death rate for Black people declines, but higher risk remains
The cancer death rate decreased 49% among Black men and 33% among Black women between 1991 and 2022, according to ACS' Cancer Statistics for African American and Black People, 2025.
However, Black people continue to have a higher cancer burden than other racial or ethnic groups, researchers found.
"Overall declines in cancer mortality rates in Black people largely reflect behavioral changes, such as historical declines in cigarette smoking among Black teens, as well as advances in treatment and earlier detection for some cancers," said Rebecca Siegel, senior scientific director of surveillance research at the American Cancer Society.
"Yet, this population persistently experiences a much higher mortality burden than other racial and ethnic groups for many cancers," Siegel added in a news release. "We must reverse course."
The ACS report also found that the risk of death among Black patients is twice that of white folks when it comes to myeloma, prostate, endometrial and stomach cancers.
Likewise, death rates among Black people for colon, breast, cervical and liver cancers are 40% to 50% higher than those for white patients, the report says.
Overall, survival is lower in Black people than in white people for almost every type and stage of cancer, with the largest gaps involving melanoma, endometrial and cervical cancers, researchers found.
"This report highlights the disparities the Black community has faced for decades," Dr. Wayne Frederick, the society's interim chief executive officer, said in a news release.
"While the decline in cancer mortality rates is encouraging, the stark inequities in incidence and survival for many cancers underscore the urgent need for targeted research and interventions," he added.
The report also found that:
• Black men experienced the most significant relative decline in cancer deaths at nearly every age, compared to Black women and white people. This included a 65% to 67% decrease in deaths among those between 40 and 59 years of age.
• The most commonly diagnosed cancers continue to be prostate (44% among males), breast (34% among females), lung (10%) and colon (8%). These types of cancer account for 58% of all new cancers diagnosed among Black people.
• Black men have a 67% higher prostate cancer case rate compared to White men and are more than twice as likely to die from it.
• Black women have a 38% higher risk of dying from breast cancer compared to White women, despite a 5% lower likelihood of being diagnosed with the disease.
• Endometrial cancer cases continue to increase among Black women by 2% per year.
"Future research should not only explore the influence of systemic racism on health, but also develop mechanisms to implement change, including increasing diversity in clinical trials," Dr. William Dahut, chief scientific officer of the society, said in a news release.
"Given this latest data, it's also more important than ever to understand how to reduce your chance of getting cancer," Dahut added. "This means taking preventative health measures, like understanding your risk profile, maintaining a healthy lifestyle, and keeping up on cancer screenings to catch the disease as early as possible."
The new report, published Thursday, appears in the journal CA: A Cancer Journal for Clinicians.
More information
The U.S. Centers for Disease Control and Prevention has more about cancer and Black people.
Copyright © 2025 HealthDay. All rights reserved.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 hours ago
- Yahoo
Man who went blind after drinking alcohol in Laos now raising awareness
A man who went blind after drinking alcohol in Laos is working with other affected families to campaign for awareness of methanol poisoning. Calum Macdonald had a night out in Vang Vieng in November last year and the next day his vision was 'engulfed in this blinding white light', he told BBC Breakfast. Police in Laos have previously detained several people in connection with the deaths of six people who are believed to have been poisoned, including Simone White, 28, from Orpington, Kent. Methanol is sometimes used by disreputable bars as a cheaper alternative to ethanol but can cause severe poisoning or death. Mr Macdonald was at a hostel where free whisky and vodka shots were offered, and he mixed them with soft drinks, he said. He told how he was on a bus crossing into Vietnam when he noticed something was wrong. He told BBC Breakfast: 'The point at which I really started to notice some strange side effects was we briefly got off the bus to cross the border into Vietnam, and we went through the border office – we had to fill out a number of forms to get across to the other side – and at that point, sort of my entire vision was engulfed in this blinding white light. 'And I just thought, you know, this is very strange. I couldn't actually see where I was walking.' He added: 'We arrived in Hanoi, and at that point, the kind of white light in my eyes had diminished, and it wasn't until we got to our hotel room and my friends and I were sitting in the room, and I said to my friends, why are we sitting in the dark here? Let's turn on a light. And they informed me that the light was, in fact, already on.' Mr Macdonald then went to hospital and said on the journey there he 'really started to struggle to breathe' and could 'barely get my words out'. He said a number of tests were carried out initially but it was not until he got back to England when he was in hospital and they 'really sort of indicated that it was definitely related to something I'd been drinking'. Mr Macdonald is now speaking out as he wants information to be available to people about methanol poisoning, especially students who might be preparing to go on a gap year. He said: 'I think I definitely feel a sense of responsibility as someone who's been lucky enough to survive this, to try and get the message out. Because I know certainly, if I'd known about it, I wouldn't be in this situation. 'And I know I have a lot of friends that have also done similar sort of gap years in travelling around even that particular area. And so definitely, I think it's quite important. 'I've had the opportunity to speak to a number of other families that have been affected by this, and they're far more knowledgeable and have been campaigning for awareness for a lot longer than I have been involved. And what they tend to say generally is that sometimes the advice isn't put in strong enough terms. 'And so I think, I guess if I was to put out a recommendation to people, although I'm certainly not an expert or a medical professional, I would probably say that if you did want to drink alcohol in some of the affected countries, probably just to avoid spirits entirely. 'I think it would be nice, even if we could get some more information directly into universities, because I think that's the age of people that are really considering doing these kinds of trips, I think that would be a great thing.' The Foreign, Commonwealth and Development Office has been approached to comment.
Medscape
a day ago
- Medscape
Diabetes Tied to Slower Brain Recovery After TBI
TOPLINE: Diabetes was associated with reduced global cognition 2 weeks after traumatic brain injury (TBI) and less improvement in processing speed throughout the first year post-TBI compared to not having diabetes, a new cohort study showed. METHODOLOGY: The prospective cohort TRACK-TBI study included more than 1000 participants aged 17 years or older with TBI (mean age, 39 years; 67% men; 76% White individuals) who presented to one of 18 level 1 trauma centers in the US between 2014 and 2018. Participants underwent cognitive assessments at 2 weeks, 6 months, and 1 year post-injury that evaluated verbal episodic memory, executive function, and processing speed alone and combined into a global cognitive factor score. Researchers analyzed associations between cognitive outcomes and the vascular risk factors of hypertension (17%), diabetes (7.5%), hyperlipidemia (9%), and smoking (30%). They adjusted the analysis for age, sex, race, ethnicity, education, severity of TBI, and histories of TBI and psychiatric conditions. TAKEAWAY: After adjustment for confounders, participants with diabetes had lower global cognitive factor scores at 2 weeks post-injury than those without diabetes (mean difference in change, -0.25; P < .05) and showed less improvement in processing speed over the first year post-injury (mean difference, -0.26; P < .05). Individuals with two or more vascular risk factors had lower global cognitive factor scores at 2 weeks post-injury than those without any vascular risk factors (mean difference, -0.21; P < .05), as well as worse verbal memory and processing speed (mean differences, -0.18 and -0.22, respectively; P < .05 for both). However, they had similar improvement over the first year. Cognitive performance did not differ significantly by hypertension, hyperlipidemia, or smoking status. In sensitivity analyses, participants with treated diabetes had worse cognitive outcomes than those without diabetes, including lower global cognitive factor scores at 2 weeks (mean difference, -0.32) and less improvement in global cognitive function over 1 year (mean difference, -0.29). IN PRACTICE: 'Given the modifiable nature of comorbid vascular risk factors, future work interrogating postinjury changes in vascular risk factor burden, over longer follow-up, is warranted,' the investigators wrote. SOURCE: The study was led by Andrea L. C. Schneider, MD, PhD, University of Pennsylvania Perelman School of Medicine, Philadelphia. It was published online on August 8 in JAMA Network Open. LIMITATIONS: Vascular risk factors were only assessed at enrollment, preventing the evaluation of post-injury changes in risk factor status. Information on disease duration or severity were unavailable. The study also experienced significant attrition leading to missing data. Additionally, the findings could not be generalized to milder injuries or more severe TBI cases managed beyond level 1 trauma centers. DISCLOSURES: The study was funded by the National Institute for Neurological Disorders and Stroke and by a grant from the Department of Defense. Several investigators reported having financial or other ties with various sources. Full details are provided in the original article. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Axios
3 days ago
- Axios
At-home cervical cancer test rolls out in California
The first FDA-approved at-home cervical cancer screening device launched this week in California. Why it matters: Cervical cancer is largely preventable, yet 1 in 4 U.S. women aren't up to date on screenings for the disease, per the CDC. Teal Health's goal is to make the testing experience feel less invasive than a Pap smear, which can often cause pain. Driving the news: The Teal Wand allows people to self-collect a vaginal sample to test for HPV, the virus that causes nearly all cervical cancers. The San Francisco women's health company spearheading the device says it uses the same HPV test used in clinics and merely differs in the method of collection. The big picture: California records about 7.3 cervical cancer cases per 100,000 people every year, slightly under the national rate of 7.5. The incidence rate varies among racial groups, however, with Hispanics generally seeing higher figures. Nationwide, Black and Indigenous people also experience higher rates of cervical cancer and mortality compared to white women. "Several studies have shown that the availability of self-screening can boost participation in cervical cancer screening among underscreened persons—a population most likely to benefit in terms of cancer prevention," UCSF obstetrician-gynecologist George F. Sawaya told Axios via email. In 2023, cervical cancer screenings in the U.S. remained 14% lower than pre-pandemic levels, per a March journal article. Yes, but: It's equally critical to ensure those with positive test results get reliable follow-ups and treatment, Sawaya added. How it works: To take a sample, the wand — similar to a tampon in its dimensions — is inserted into the vagina and deploys a sponge to collect cells from the cervix. Once the sponge is extracted, it's placed in a vial and mailed to the lab. Teal medical providers then review the results and follow up via telehealth. The kit, which is shipped to your door, is available for purchase online and costs $99 with in-network insurance and $249 via credit card or HSA/FSA payment. By the numbers: Self-collected samples using the wand have proven to detect cervical precancer 96% of the time, similar to clinician-collected ones, Teal Health's 16-site clinical trials found. Eighty-six percent of participants said they'd be more likely to stay up to date with screenings if they could do it at home, per the trials. What they're saying: A lot of people don't recognize the importance of getting tested regularly because it's not always clear what a Pap smear is for, Teal Health co-founder and CEO Kara Egan told Axios. Lack of appointments, time conflicts and discomfort with the exam are also top reasons for not screening, Egan added. The wand was designed to alleviate those concerns, she said, offering the "same accuracy, but just comfortably and privately from home."
